OC 50.3 Inhibitor Development Upon Switch After 50 EDs from Plasma-Derived to Recombinant FVIII in Pups with Severe Haemophilia A: The PUP-SWITCH Study Results — Seied Mehdi Miri (2023) | RDL Network
OC 50.3 Inhibitor Development Upon Switch After 50 EDs from Plasma-Derived to Recombinant FVIII in Pups with Severe Haemophilia A: The PUP-SWITCH Study Results
Research and Practice in Thrombosis and Haemostasis 7: 100426-100426
Laura Bannach Jardim, Johanna G. van der Bom, Suely Meireles Rezende, L. van Vulpen, Jeroen Eikenboom, Erik A.M. Beckers, L. Hooijmeijer, Michiel Coppens, Saskia E.M. Schols, Frank W.G. Leebeek, M.H.E. Driessens, Frits R. Rosendaal, Samantha C. Gouw
Research and Practice in Thrombosis and Haemostasis
Discussion(0)
No comments yet. Be the first to comment.